HUGO BELLEN to Parkinson Disease
This is a "connection" page, showing publications HUGO BELLEN has written about Parkinson Disease.
Connection Strength
2.212
-
Does glial lipid dysregulation alter sleep in Alzheimer's and Parkinson's disease? Trends Mol Med. 2024 Oct; 30(10):913-923.
Score: 0.545
-
'Fly-ing' from rare to common neurodegenerative disease mechanisms. Trends Genet. 2022 09; 38(9):972-984.
Score: 0.473
-
Sphingolipids in the Pathogenesis of Parkinson's Disease and Parkinsonism. Trends Endocrinol Metab. 2019 02; 30(2):106-117.
Score: 0.374
-
Phospholipase PLA2G6, a Parkinsonism-Associated Gene, Affects Vps26 and Vps35, Retromer Function, and Ceramide Levels, Similar to a-Synuclein Gain. Cell Metab. 2018 10 02; 28(4):605-618.e6.
Score: 0.362
-
A mitocentric view of Parkinson's disease. Annu Rev Neurosci. 2014; 37:137-59.
Score: 0.272
-
Elevated COUP-TFII expression in dopaminergic neurons accelerates the progression of Parkinson's disease through mitochondrial dysfunction. PLoS Genet. 2020 06; 16(6):e1008868.
Score: 0.104
-
The retromer complex in development and disease. Development. 2015 Jul 15; 142(14):2392-6.
Score: 0.074
-
Drosophila parkin mutants have decreased mass and cell size and increased sensitivity to oxygen radical stress. Development. 2004 May; 131(9):2183-94.
Score: 0.008